Stock listing
Trisalus Life Sciences, Inc.
Selected listing: TLSI · BOATS · USD · US
Trisalus Life Sciences, Inc. (BOATS:TLSI), Health Technology. Latest release Sep 22, 2026: TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance…
- Ticker
- BOATS:TLSI
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- BOATS
- Currency
- USD
About Trisalus Life Sciences, Inc.
Trisalus Life Sciences, Inc. (Ticker: TLSI) is a public company based in the United States, focusing on innovative solutions in the life sciences sector. The company operates within a dynamic market, contributing to the ongoing development of healthcare solutions.
Latest news from Trisalus Life Sciences, Inc.
TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization
September 22, 2026
TriSalus Life Sciences Reports Second Quarter 2026 Results
August 6, 2026
TriSalus Life Sciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 28, 2026
TriSalus Life Sciences to Host Second Quarter 2026 Financial Results Conference Call
July 16, 2026
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer
June 10, 2026
Events
Research Trisalus Life Sciences, Inc.
Trisalus Life Sciences, Inc. company profile
View the public company page for Trisalus Life Sciences, Inc. on 6ix.
Trisalus Life Sciences, Inc. news
Read company news and market updates connected to Trisalus Life Sciences, Inc..
Trisalus Life Sciences, Inc. investor events
Find investor webinars, events, and replay context for Trisalus Life Sciences, Inc..